Tevogen Inc. (TVGNW) stock
TVGNWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as TVGN
$0.09+0.01 (+18.24%)
Close on Oct 30, 2026Market cap $38.42MP/E –Yield –
Tevogen total assets
Total assets on the balance sheet at the end of each period.
Tevogen's total assets was $4.73M at Jun 30, 2026. For fiscal 2025 it was $4.38M, up 26.6% from the year before. The highest annual figure on record is $357.14M in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.38M | +26.6% |
| FY2024 | Dec 31, 2024 | $3.46M | -37.1% |
| FY2023 | Dec 31, 2023 | $5.51M | -98.5% |
| FY2022 | Dec 31, 2022 | $357.14M | +1.2% |
| FY2021 | Dec 31, 2021 | $352.85M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $4.73M | +10.7% |
| Q1 FY2026 | Mar 31, 2026 | $4.92M | +20.8% |
| Q4 FY2025 | Dec 31, 2025 | $4.38M | +26.6% |
| Q3 FY2025 | Sep 30, 2025 | $4.49M | +4.8% |
| Q2 FY2025 | Jun 30, 2025 | $4.27M | +29.0% |
| Q1 FY2025 | Mar 31, 2025 | $4.07M | +21.1% |
| Q4 FY2024 | Dec 31, 2024 | $3.46M | -37.1% |
| Q3 FY2024 | Sep 30, 2024 | $4.29M | -83.8% |
| Q2 FY2024 | Jun 30, 2024 | $3.31M | -87.4% |
| Q1 FY2024 | Mar 31, 2024 | $3.36M | -86.8% |
| Q4 FY2023 | Dec 31, 2023 | $5.51M | -98.5% |
| Q3 FY2023 | Sep 30, 2023 | $26.41M | -92.6% |
| Q2 FY2023 | Jun 30, 2023 | $26.38M | -92.5% |
| Q1 FY2023 | Mar 31, 2023 | $25.47M | -92.8% |
| Q4 FY2022 | Dec 31, 2022 | $357.14M | +1.2% |
| Q3 FY2022 | Sep 30, 2022 | $354.54M | +212469.3% |
| Q2 FY2022 | Jun 30, 2022 | $352.98M | – |
| Q1 FY2022 | Mar 31, 2022 | $352.83M | – |
| Q4 FY2021 | Dec 31, 2021 | $352.85M | – |
| Q3 FY2021 | Sep 30, 2021 | $166.79K | – |